相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells
Aslamuzzaman Kazi et al.
CELL CYCLE (2009)
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2009)
Non-Peptidic Small Molecule Inhibitors Against Bcl-2 for Cancer Therapy
Asfar S. Azmi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
BH3 Mimetic ABT-737 and a Proteasome Inhibitor Synergistically Kill Melanomas through Noxa-Dependent Apoptosis
Leslie A. Miller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Blockade of Protein Geranylgeranylation Inhibits Cdk2-Dependent p27Kip1 Phosphorylation on Thr187 and Accumulates p27Kip1 in the Nucleus: Implications for Breast Cancer Therapy
Aslamuzzaman Kazi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
Luca Paoluzzi et al.
BLOOD (2008)
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
Luca Paoluzzi et al.
BLOOD (2008)
Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax
Jonathan F. Lovell et al.
CELL (2008)
BAX activation is initiated at a novel interaction site
Evripidis Gavathiotis et al.
NATURE (2008)
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Jerry E. Chipuk et al.
TRENDS IN CELL BIOLOGY (2008)
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bim and the pro-survival bcl-2 proteins - Opposites attract, ERK repels
Katherine E. Ewings et al.
CELL CYCLE (2007)
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Peter E. Czabotar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1
Ramzi M. Mohammad et al.
CLINICAL CANCER RESEARCH (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
Milan Bruncko et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
J Iqbal et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Life in the balance: how BH3-only proteins induce apoptosis
SN Willis et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis
Y Takahashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Terphenyl-based bak BH3 α-helical proteomimetics as low-molecular-weight antagonists of Bcl-XL
H Yin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia
A Saxena et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: New avenues for cancer chemoprevention and chemotherapy
M Pellecchia et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Cytochrome C-mediated apoptosis
XJ Jiang et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
The structure of a Bcl-xL/Bim fragment complex:: implications for bim function
XQ Liu et al.
IMMUNITY (2003)
Bcl-XL protects BimEL-induced Bax conformational change and cytochrome c release independent of interacting with Bax or BimEL
H Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Development of a potent Bcl-xL antagonist based on α-helix mimicry
O Kutzki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Inhibition of Bcl-XL phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis
A Kazi et al.
MOLECULAR PHARMACOLOGY (2002)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
A Degterev et al.
NATURE CELL BIOLOGY (2001)